OncoPrecision

New York, NY · Founded 2020 · Privately Held (backing)

Developer of a patient micro avatar platform designed to get the cancer therapy to the right patient. OncoPrecision is based in New York, NY and was founded in 2020. Its last reported valuation was $18 million in Oct 2025. It has raised $8.7 million.

Last reported valuation

$18.0M

Oct 2026

Priced at

—

Total raised

$8.7M

Last round

—

How much has OncoPrecision raised?

$8.7Macross 0 recorded rounds

Free account

More of OncoPrecision with a free account

·Watch OncoPrecision: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

OncoPrecision investors

8 investors are on record for OncoPrecision, including SOSV, Endless Frontier Labs, IndieBio and New York Ventures.

For fundraisers

Raising for a company like OncoPrecision?

8 investors have backed OncoPrecision.

See all 8 investors →

Frequently asked about OncoPrecision

How much has OncoPrecision raised?: OncoPrecision has raised $8.7M in total across 0 recorded funding rounds.